Zhejiang Hisun Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 10,373.07 million compared to CNY 12,036.69 million a year ago. Net loss was CNY 93.17 million compared to net income of CNY 488.86 million a year ago.

Basic loss per share from continuing operations was CNY 0.08 compared to basic earnings per share from continuing operations of CNY 0.42 a year ago. Diluted loss per share from continuing operations was CNY 0.08 compared to diluted earnings per share from continuing operations of CNY 0.42 a year ago.